DALLAS, Sept. 20, 2019 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced an anticipated substantial increase in sales in Q4 2019 coming from its first hemp harvest now underway. The company announced on Monday this week having initiated its first hemp harvest. KALY has entered into a consignment contract to ultimately extract CBD from a hemp crop managed by a licensed hemp grower in the State of New York and in turn sell the CBD extract under KALY's own brand. The contract is anticipated to generate as much as $5 million in revenue for KALY. Management anticipates realizing the first revenue from the consignment contract in the fourth quarter of this year.
KALY Analyst Coverage Speculating $0.05 PPS
The company recently announced a new analyst report from Goldman Small Cap Research covering the KALY's recent biopharmaceutical cannabis extract business development updates. The report can be found in its entirety on Goldman's website www.goldmanresearch.com. The report speculates a potential KALY price per share of $0.05.
To view the full report visit: https://www.goldmanresearch.com/201908131248/Opportunity-Research/next-gen-edtech-firm-on-a-roll.html
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
SOURCE Kali-Extracts, Inc.